Key result
Atropine premedication during electroconvulsive therapy worsened cardiac autonomic dysfunction compared to no atropine.
Why the study?
Does atropine premedication worsen cardiac autonomic dysfunction in psychiatric patients undergoing electroconvulsive therapy?
RCT (n=41)
crossover
Does atropine premedication worsen cardiac autonomic dysfunction in psychiatric patients undergoing electroconvulsive therapy?
Answers are grounded in this paper and cite their sources.
Atropine premedication during ECT significantly worsens cardiac autonomic dysfunction and should be restricted to patients susceptible to bradyarrhythmia.
OBJECTIVES: Electroconvulsive therapy (ECT) results in significant cardiovascular changes. The acute cardiac autonomic changes during ECT remain unexplored. The primary objective of this study was to compare autonomic dysfunction with and without atropine premedication during ECT and secondarily to evaluate dysautonomia across psychiatric diagnoses before and after ECT. METHODS: In this crossover study, 41 psychiatric patients were monitored during 82 ECT sessions. Patients were randomized either to receive atropine or not to receive atropine during their second ECT session and were crossed over during their third session. Heart rate, blood pressure, and oxygen saturation were continuously monitored from stimulus application until 300 seconds after ECT. Demographic characteristics and ANSiscope indices derived pre- and post-ECT were collected. RESULTS: Autonomic dysfunction (%) before ECT was similar between atropine and no-atropine sessions (32.4 ± 15.7 vs 32.8 ± 16.7; 95% confidence interval, -7.6 to 6.7; P = 0.90) but increased significantly after ECT to 60.9 ± 16.3 and to 47.0 ± 17.3, respectively, and this difference was significant (95% confidence interval, 6.5-21.3; P < 0.001). There was no difference in the autonomic function across psychiatric diagnoses both before (P = 0.07) and after ECT (P = 0.12). CONCLUSIONS: Cardiac autonomic dysfunction worsens after ECT in patients with psychiatric illnesses and to a significantly greater extent with atropine premedication. The degree of dysautonomia is similar across various psychiatric diagnoses both before and after ECT. Atropine premedication during ECT should be restricted to select patients susceptible to bradyarrhythmia and could be avoided in others.
No takes yet. Share an insight, caveat, or question.
Jadhav et al. (2017) conducted an RCT in psychiatric illnesses (n=41). Atropine premedication vs. No atropine premedication was evaluated on Autonomic dysfunction (%) after ECT (95% CI 6.5-21.3, p=<0.001). Atropine premedication during electroconvulsive therapy worsened cardiac autonomic dysfunction compared to no atropine.
Synapse has enriched 10 related papers. Consider them for comparative context: